Biocon gets drug regulator#39;s nod for CytoSorb device to treat critical COVID-19 patients

"The goal of CytoSorb therapy is to reduce cytokine storm and the deadly inflammatory response through blood purification so that this injury may be mitigated or prevented," the company added.

from Moneycontrol Business News https://ift.tt/3gtAGyI